Compare Illumina vs Singular Genomics
Customers evaluate the quality of Illumina's products using the following success metrics.
Overview
Illumina is 26 yrs old and is based in United States.
Illumina works to apply technologies and revolutionary assays to the analysis of genetic variation and function. It offers collaborative interactions, rapid delivery of solutions, and focuses on customers. Illumina's array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic. The company was founded in 1998 and is based in San Diego, California.
Singular Genomics is 8 yrs old and is based in United States.
Singular Genomics (NASDAQ: OMIC) develops next-generation sequencing and multi-omics technologies. It helps to build products that empower researchers and clinicians. The company was founded in 2016 and is based in San Diego, California.
Demo Video
Leadership
Maneesh Jain (Founder)
David L. Barker (Founder)
Funding
Investors
LRG Capital Group, ARCH Venture Partners
ARCH Venture Partners and F-Prime Capital
Product
Information not available because Illumina has not claimed their profile.
Work for Illumina? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Illumina?
Claim your profile now.
Why Singular Genomics beats Illumina
- Speed, flexibility, scale and longer reads
Benefits
- Flexibility
- Accuracy
- Speed
Products
G4 Integrated Solution
The G4 Instrument is a benchtop next-generation sequencer designed to produce fast and accurate genetic sequencing results for specific targeted applications, including rare variant detection with high definition and synthetic long read (SLR) sequencing, which can be applied in rapidly growing markets such as oncology, including liquid biopsy detection of cell-free DNA, and immune response profiling to help researchers better harness the immune system in fighting infectious diseases, autoimmune disorders and immunotherapies for cancer.
Customers
Singular Genomics works with 2 known companies.
Known Partners
Sanford Burnham, Fate Therapeutics
Why They Buy
News & Analysis
Illumina has been mentioned in our research 4 times.
Singular Genomics has not been mentioned in our research.
Research Articles
Expert Collections
Synthetic Biology
382 items
Conference Exhibitors
5,501 items
HLTH is a healthcare event bringing together startups and large companies from pharma, health insurance, business intelligence, and more to discuss the shifting landscape of healthcare